ASPCA Sees Increase in Number of Calls to Poison Control Center in 2024, Including Rise in Cases Related to Hallucinogenic Mushroom Consumption
NEW YORK, March 12, 2025 /PRNewswire/ -- In recognition of Poison Prevention Week (March 16-22, 2025), the ASPCA® (The American Society for the Prevention of Cruelty to Animals®) is releasing its annual list of top pet toxins encountered by veterinary professionals at the ASPCA Animal Poison Control Center (APCC). In 2024, APCC staff responded to more than 451,000 calls related to toxic substance, plant and poison exposures in animals, representing a nearly 4% increase in calls compared to the year prior.
Each year, APCC's staff of veterinary toxicologists examine data from the previous year to identify trends and raise awareness about the top toxins that pets are exposed to. By providing toxicology resources, consulting services, and diagnostic and clinical treatment, the APCC's team of highly trained veterinary professionals – including 25 veterinarians boarded in toxicology – assisted over 322,000 animals nationwide in 2024.
In 2024, over-the-counter (OTC) medications remained the top animal toxin on APCC's list, accounting for 16.5% of all exposures. Vitamins and dietary supplements were the top OTC medications called about in 2024. Accidental exposures can occur when people drop their pills or leave bottles of pain medications like ibuprofen or naproxen where pets can access them.
Food and drink followed closely in the number two spot, accounting for 16.1% of all exposures in 2024. The primary items in this category that pet owners called about were protein drinks and bars, xylitol-laden chewing gum, grapes, raisins, onions and garlic. Chocolate exposures also slightly increased compared to 2023, coming in at 13.6% of exposures last year. Accidental chocolate ingestion was particularly prevalent among dogs, who are more prone to eating an entire chocolate bar or tray of brownies as opposed to cats who might nibble on a chocolatey treat and then lose interest.
Recreational drugs including marijuana-based drugs and hallucinogenic mushrooms (psilocybin and muscarine), which first made the APCC top ten list in 2022, remained in the tenth spot for the third year in a row. While exposures to THC-based drugs are decreasing, likely due to increased knowledge among pet owners about the dangers of marijuana products, hallucinogenic mushroom exposures increased as these drugs became more widely legalized and accessible.
'Every year, we notice an increase in the number of calls from concerned pet owners regarding potential toxin exposure. This trend shows a growing awareness of the potential risks faced by our beloved pets,' says Dr. Tina Wismer, senior director of toxicology at the ASPCA Animal Poison Control Center. 'For over 45 years, the APCC has been a trusted resource for both pet owners and veterinarians during emergencies involving toxic ingestions and exposures. We truly understand the anxiety that comes with these situations, and we are committed to supporting pet families in need, positioning ourselves as a leading resource in veterinary toxicology to protect and save more precious animal lives.'
The APCC's list of top toxins encountered in 2024 can be downloaded at the link HERE. This information is presented in partnership with long-time ASPCA supporter BuzzRx ®, which offers free prescription discount cards benefiting not-for-profit organizations like the ASPCA. Each time you save on prescriptions for yourself or your pets using the card, BuzzRx donates $1 to the ASPCA.
Since its inception over 45 years ago, the APCC 24-hour-a-day, 365-days-a-year hotline has served as a critical and trusted resource for pet owners and veterinarians nationwide in keeping animals safe and healthy. The APCC has developed a sophisticated veterinary database system called AnTox™ that helps identify and characterize toxic effects of substances in animals and helps APCC veterinary professionals in their lifesaving work. In addition to assisting pet owners facing medical emergencies at home, the APCC works closely with veterinary clinics to provide their deep expertise to save more animal lives.
For more information about the ASPCA Animal Poison Control Center, visit aspca.org/poison. If you think your pet may have ingested a potentially poisonous substance, call the APCC at (888) 426-4435 or contact your local veterinarian as soon as possible.
About the ASPCA®
Founded in 1866, the ASPCA® (The American Society for the Prevention of Cruelty to Animals®) was the first animal welfare organization to be established in North America and today serves as the nation's leading voice for vulnerable and victimized animals. As a 501(c)(3) not-for-profit corporation with more than two million supporters nationwide, the ASPCA is committed to preventing cruelty to dogs, cats, equines, and farm animals throughout the United States. The ASPCA assists animals in need through on-the-ground disaster and cruelty interventions, behavioral rehabilitation, animal placement, legal and legislative advocacy, and the advancement of the sheltering and veterinary community through research, training, and resources. For more information, visit www.aspca.org, and follow the ASPCA on Facebook, X, Instagram, and TikTok.

Try Our AI Features
Explore what Daily8 AI can do for you:
Comments
No comments yet...
Related Articles
Yahoo
3 hours ago
- Yahoo
FuturHealth Offers Users Complimentary Access to Apple Fitness+ for Movement and Motivation
SAN DIEGO, Aug. 11, 2025 /PRNewswire/ -- FuturHealth, a leading provider of personalized weight-loss solutions, today announced that it will bring Apple Fitness+, the award-winning fitness and wellness service that is welcoming to all, to members who are enrolled in a FuturHealth program at no additional cost. The offer gives FuturHealth users additional fitness tools to help them reach their goals. This offer underscores FuturHealth's commitment to empowering members with a comprehensive toolkit that supports sustainable, personalized weight loss journeys, whether with medication, nutrition, fitness, or a combination of all three. "Our top priority has always been to help people on a weight loss journey experience real, long-lasting results through holistic lifestyle changes and personalized support," said Luke Mahoney, co-founder and CEO of FuturHealth. "With this Fitness+ offer, users can tap into thousands of workouts and meditations—wherever and whenever they choose—at no extra cost." Fitness+ offers users access to thousands of workouts and meditations in 4K Ultra High Definition on iPhone, iPad and Apple TV, ranging from 5 to 45 minutes across 12 different types including Strength, HIIT, Treadmill, Rowing, Cycling, Yoga, and more. All it takes is an iPhone to get started— and with Apple Watch, users can unlock even more motivation through personalized, real-time metrics right onscreen. Fitness+ workouts feature energizing music playlists by today's top artists all led by a diverse and inclusive team of trainers that can be done anytime, anywhere. Fitness+ also offers inspiring audio experiences including Time to Walk and Time to Run. Users can access the Fitness+ offer by simply tapping on the Apple Fitness+ module on the home screen in the FuturHealth app. This announcement follows a series of significant milestones for the company. This year alone, FuturHealth launched Affirm's flexible payment options for members, partnered with Valisure to ensure the highest quality and safety standards for weight-loss medications, and released compelling efficacy data showing that combining the FuturHealth Program with weight-loss treatments significantly enhances weight loss outcomes compared to medication alone. For more information about FuturHealth's innovative approach, visit About FuturHealth:FuturHealth is your partner in weight loss, providing personalized guidance designed to work with your everyday life. Together with a team of doctors, dietitians, and weight-loss experts, we combine scientifically-proven medications with clinically-crafted, expertly-curated meals for quick, easy, effective, and affordable wins. Founded with a mission to create a holistic and personalized alternative to traditional, one-size-fits-all weight-loss solutions, we meet each person where they are on their unique journey, empowering them to confidently take control of their well-being at every step of the way. With a network of 350+ providers across 48 states, FuturHealth has transformed the lives of over 1.5 million patients and counting. In under a year, it has achieved an extraordinary 980% growth in active patients and facilitated over 6 billion online interactions. View original content to download multimedia: SOURCE FuturHealth
Yahoo
4 hours ago
- Yahoo
Dräger Atlan anesthesia workstations obtain Authority to Operate (ATO) under Risk Management Framework
Certification ensures highest level of patient data security a medical device can attain Effective 7/14/2025 and expiring on 7/14/2028 under eMASS System ID #4060 TELFORD, Pa., Aug. 11, 2025 /PRNewswire/ -- Today Dräger, an international leader in medical and safety technologies, announced that the company's Atlan A350/A350 XL series of anesthesia workstations received Authority to Operate (ATO) certification under the Department of Defense's (DoD) Risk Management Framework (RMF) eMASS #4060. "Cyberattacks continue to be a serious threat to hospitals – both clinically and financially," said President and CEO for Draeger, Inc., Lothar Thielen. "To help hospitals meet this challenge, Dräger embeds the latest cybersecurity technology deeply into our development processes. Our new Atlan anesthesia workstations now carry ATO certification, which is the highest level of security a medical device can hold." Continuing a longstanding commitment to patient data securityCertification of Dräger's Atlan A350/A350XL anesthesia workstation follows the certifications of the Perseus A500 (eMASS # 2852) and Fabius MRI (eMASS # 2875) anesthesia workstations. Now with the Atlan certification, Dräger anesthesia customers can have confidence knowing that Dräger's entire anesthesia machine portfolio has gone through this rigorous cyber-security review process. Benefits of ATO-certified medical devicesMedical devices that have achieved an Authority to Operate (ATO) under the Risk Management Framework (RMF) offer significant advantages to hospitals, including: Enhanced security: Rigorous security assessments ensure that these devices meet high standards for protecting sensitive patient data and maintaining the integrity of medical operations Compliance assurance: Devices that comply with federal regulations and standards reduce the risk of legal and regulatory issues Reliability and trust: Hospitals can trust that these devices have been thoroughly vetted for security and performance, leading to greater confidence in their use in critical environments Interoperability: Devices with ATO are often designed to integrate seamlessly with other systems within the healthcare network, enhancing overall efficiency and effectiveness Continuous monitoring: Ongoing monitoring and updates continually address new security threats, ensuring that devices remain secure over time Faster installation: ATO-certified devices streamline the process of integrating device data with electronic medical records, centralized alarm stations, and remote notifications These benefits enable ATO-certified medical devices to provide stronger patient data protection and carry a lower risk of cyberattacks. More information:Dräger Atlan A350/A350 XL family of devices: You can find more information and pictures in our press center: Dräger. Technology for is a leading international medical and safety technology company. Our products protect, support and save lives. Founded in Lübeck, Germany in 1889, Dräger generated global sales of around EUR 3,4 billion in 2024. The Lübeck-based company is represented in more than 190 countries and employs more than 16,000 people worldwide. For more information, visit ContactCommunications: Melanie Kamann, Tel. +49 451 882-3202, Press Contact North America: Laura Edwards, Tel. +1 215 565-5868, Investor Relations: Thomas Fischler, Tel. +49 451 882-2685, View original content to download multimedia: SOURCE Draeger
Yahoo
5 hours ago
- Yahoo
Wound Care Market worth US$30.48 billion by 2030 with 6.5% CAGR
DELRAY BEACH, Fla., Aug. 11, 2025 /PRNewswire/ -- The global Wound Care Market, valued at US$20.97 billion in 2024 stood at US$22.22 billion in 2025 and is projected to advance at a resilient CAGR of 6.5% from 2025 to 2030, culminating in a forecasted valuation of US$30.48 billion by the end of the period. The wound care market is primarily driven by the increasing cases of traumatic and burn injuries, growing prevalence of chronic diseases, and rising geriatric population. These factors have contributed to the higher demand for effective wound management solutions. Additionally, supportive government initiatives and reimbursement frameworks further bolster market growth. However, the high cost of advanced wound care products and associated risks may limit their widespread adoption. On the other hand, emerging economies offer significant growth opportunities, supported by ongoing technological advancements in wound care. Despite this, market expansion is challenged by a shortage of trained healthcare professionals and limited awareness in underdeveloped regions. Download PDF Brochure: Browse in-depth TOC on "Wound Care Market" 589 - Tables 61 - Figures 457 - Pages By wound type, the wound care market is divided into two main segments based on wound type: chronic wounds and acute wounds. Chronic wounds are further divided into diabetic foot ulcers, pressure ulcers, venous leg ulcers, and other chronic wounds. The chronic wounds segment of the wound care held the largest market share in 2024. Chronic wounds are more prominent due to their high incidence and the need for quick, targeted treatment. These types of wounds require wound care products to prevent infection and support faster and efficient healing. Additionally, increasing surgical procedures and accidental injuries worldwide continue to drive demand in this segment. By end users, the wound care market is divided into hospitals & clinics, home care settings, long-term care facilities, and other end users. Among these end users, the hospitals & clinics segment held the largest market share in 2024 for wound care. Hospitals & clinics are further divided into inpatient settings and outpatient settings. Hospitals & clinics lead the market due to their ready access to advanced technologies and trained medical staff. These settings handle a larger number of complex wound patients, requiring specialized care. Their ability to provide immediate and continuous treatment further supports their dominant role in the market. By geography, the wound care market is segmented into five major segments, namely, North America, Europe, Asia Pacific, Latin America, and the Middle East & Africa. North America had the largest market share in the wound care market in 2024. This is due to the increasing prevalence of diabetes, which leads to diabetic foot ulcers in the geriatric population. Additionally, the huge presence of wound care manufacturing companies in the region is increasing the market growth. The US has also observed a rise in obesity and road accidents, which has boosted the wound care market in North America. Request Sample Pages : Prominent players in the wound care market include Solventum (US), Johnson & Johnson Services, Inc. (US), Smith+ Nephew (UK), Convatec Group PLC (UK), Coloplast Group (Denmark), Cardinal Health (US), Mölnlycke AB (Sweden), Integra LifeSciences Corporation (US), PAUL HARTMANN AG (Germany), SE (Germany), Organogenesis Inc. (US), MIMEDX Group, Inc. (US), Essity Aktlebolag (Sweden), Avery Dennison Corporation (US), Mativ Holdings, Inc. (US), Owens & Minor (US), Zimmer Biomet (US), Bioventus (US), Medtronic (Ireland), and Baxter (US). Solventum (US): Following its spinoff from 3M in April 2024, Solventum embarked on a new journey as an independent company. While it previously benefited from 3M's resources and brand recognition, Solventum is now focused on establishing its own identity. The company develops, manufactures, and markets a wide range of products aimed at meeting the needs of both patients and healthcare providers. Its operations are structured across four key business segments: MedSurg, Dental Solutions, Health Information Systems, and Purification & Filtration. To drive growth, Solventum is prioritizing innovation and strategic expansion. The company enhances its competitive position by combining material science with digital technologies, delivering improved clinical and economic outcomes for healthcare systems. Johnson & Johnson Services, Inc. (US) Johnson & Johnson, a global healthcare powerhouse, maintains a leading position in the wound care market through its surgical technologies arm, Ethicon. The company provides an extensive portfolio of advanced wound closure solutions, including sutures, staplers, and sealants that are widely utilized in surgical and acute care environments. Leveraging decades of clinical expertise, strong evidence-based outcomes, and a commitment to continuous innovation, the company effectively addresses a broad spectrum of surgical wound care needs. Supported by Johnson & Johnson's expansive global manufacturing and distribution infrastructure, Ethicon strengthens the company's ability to deliver high-quality, scalable, and dependable wound care solutions worldwide. Smith+Nephew (UK) The company offers a wide portfolio of wound care products, including advanced dressings and NPWT devices. It maintains a strong global market presence, largely due to its efficient distribution network. Its worldwide reach and the essential nature of its products play a key role in expanding healthcare access across both developed and emerging markets. In recent years, the company has increased its focus on research and development to create more effective and differentiated products. It invested USD 289.0 million in 2024, USD 339.0 million in 2023, and USD 345.0 million in 2022 in R&D activities. This consistent commitment to innovation has helped establish the company as a recognized name in the wound care industry. For more information, Inquire Now! Related Reports: Advanced Wound Care Market Traditional Wound Care Market Animal Wound Care Market Wound Care Biologics Market Burn Care Market Get access to the latest updates on Wound Care Companies and Wound Care Market Size About MarketsandMarkets™: MarketsandMarkets™ has been recognized as one of America's Best Management Consulting Firms by Forbes, as per their recent report. MarketsandMarkets™ is a blue ocean alternative in growth consulting and program management, leveraging a man-machine offering to drive supernormal growth for progressive organizations in the B2B space. With the widest lens on emerging technologies, we are proficient in co-creating supernormal growth for clients across the globe. Today, 80% of Fortune 2000 companies rely on MarketsandMarkets, and 90 of the top 100 companies in each sector trust us to accelerate their revenue growth. With a global clientele of over 13,000 organizations, we help businesses thrive in a disruptive ecosystem. The B2B economy is witnessing the emergence of $25 trillion in new revenue streams that are replacing existing ones within this decade. We work with clients on growth programs, helping them monetize this $25 trillion opportunity through our service lines – TAM Expansion, Go-to-Market (GTM) Strategy to Execution, Market Share Gain, Account Enablement, and Thought Leadership Marketing. Built on the 'GIVE Growth' principle, we collaborate with several Forbes Global 2000 B2B companies to keep them future-ready. Our insights and strategies are powered by industry experts, cutting-edge AI, and our Market Intelligence Cloud, KnowledgeStore™, which integrates research and provides ecosystem-wide visibility into revenue shifts. To find out more, visit or follow us on Twitter , LinkedIn and Facebook . Contact:Mr. Rohan SalgarkarMarketsandMarkets™ INC.1615 South Congress 103, Delray Beach, FL 33445USA: +1-888-600-6441Email: sales@ Our Website: Logo: View original content: SOURCE MarketsandMarkets Sign in to access your portfolio